Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral dexamethasone to prevent postembolization syndrome after hepatic conventional transarterial chemoembolization
TCTR20210518001Phase 2Not yet recruiting
- Sponsor
- Gastroenterological Association of Thailand
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in post-embolization syndrome (PES), sponsored by Gastroenterological Association of Thailand. Planned start May 2021; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
post-embolization syndrome (PES)
Beyond the preview
Go deeper on TCTR20210518001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210518001.